Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HRS-2129 for postoperative pain in abdominal surgery
NCT07185594Phase 3Recruiting
- Sponsor
- Shandong Suncadia Medicine Co., Ltd.
- Start
- Oct 2025
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of HRS-2129 in postoperative pain, sponsored by Shandong Suncadia Medicine Co., Ltd.. Started Oct 2025; status: recruiting.
02
Drugs
HRS-2129
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07185594.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07185594.